What is the debt of Repligen this year?
Repligen has a debt level of -171.73 USD this year.
Repligen Debt 2024
Repligen Debt
-171.73 USD
Ticker
RGEN
ISIN
US7599161095
WKN
870980
In 2024, Repligen's total debt was -171.73 USD, a -28.12% change from the -238.9 USD total debt recorded in the previous year.
Repligen Aktienanalyse
What does Repligen do?
Repligen Corp is an American company that was founded in 1981 and is headquartered in Waltham, Massachusetts. The company is a leading provider of products for the biopharmaceutical industry. It offers a wide range of innovative products and services that contribute to the acceleration and improvement of the development of biological drugs. The history of Repligen Corp begins in the 1980s when the company was originally founded to produce human proteins for medical purposes. Over the years, the company expanded its business and focused on the production of purification solutions for the biopharmaceutical industry. Today, Repligen is an established company in this field and serves customers around the world. Business model: Repligen Corp is a leading provider of products and services for the biopharmaceutical industry. The company focuses on the development and manufacturing of products for the purification of proteins and antibodies. These products are used by biotech and pharmaceutical customers to improve the effectiveness and safety of their products in the clinical development process. Repligen Corp is generally able to achieve good prices for its products as they are high-quality products for a high-priced industry. The company is also interested in introducing new products to the market and expanding its customer base. Various divisions: Repligen Corp offers a wide range of innovative products and services that contribute to the acceleration and improvement of the development of biological drugs. The company is divided into various divisions, including: 1. Chromaflow: Repligen's Chromaflow products offer a wide range of purification solutions for proteins and antibodies used in the biopharmaceutical industry. These products enable customers to test and develop their products faster and more effectively. 2. Protein A Adsorbent Resin: Repligen Corp offers a Protein A Adsorbent Resin used in biotherapy. It allows for highly efficient purification of therapeutics produced using Protein A. 3. Alternating Tangential Flow (ATF) Systems: Repligen's ATF system enables continuous cell culture of proteins and antibodies. This facilitates the production of biopharmaceutical products and shortens development time. 4. Process Analytical Technology (PAT): Repligen Corp's PAT system allows for accurate monitoring of the manufacturing process of biopharmaceutical products. It improves process control and reduces the risk of errors and failures. 5. Filtration products: Repligen's filtration products include disposable filters and microfiltration membranes. These products are used by customers in the biopharmaceutical industry for the purification of biological products. Products: Repligen Corp offers a wide range of innovative products and services to support the development of biological drugs. Here are some of the products offered by Repligen Corp: 1. Protein A Adsorbent Resin: This product is used in biotherapy and the biopharmaceutical industry to enable highly efficient purification of therapeutics produced using Protein A. 2. Alternating Tangential Flow (ATF) Systems: This system enables continuous cell culture of proteins and antibodies. It facilitates the production of biopharmaceutical products and shortens development time. 3. Chromaflow products: They offer a wide range of purification solutions for proteins and antibodies used in the biopharmaceutical industry. 4. PAT systems: Repligen Corp's PAT system allows for accurate monitoring of the manufacturing process of biopharmaceutical products. 5. Filtration products: Repligen's filtration products include disposable filters and membranes. These products are used by customers in the biopharmaceutical industry to purify biological products. In summary, Repligen Corp is an established company that focuses on the development and production of products and services for the biopharmaceutical industry. The company offers a wide range of innovative products that contribute to the acceleration and improvement of the development of biological drugs. With its long history and established reputation as a leading provider, Repligen Corp is a significant player in the biopharmaceutical industry. Repligen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Repligen's Debt Structure
Repligen's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Repligen's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Repligen’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Repligen’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Repligen stock
What was the debt of Repligen compared to the previous year?
The debt of Repligen has increased by -28.12% compared to the previous year dropped.
What are the consequences of high debt for investors in Repligen?
High debt can pose a risk for investors of Repligen, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Repligen?
Low debt means that Repligen has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Repligen affect the company?
An increase in debt of Repligen can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Repligen affect the company?
A reduction in debt of Repligen can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Repligen?
Some factors that can influence the debt of Repligen include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Repligen so important for investors?
The debts of Repligen are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Repligen take to change the debt?
To change the debt, Repligen can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Repligen pay?
Over the past 12 months, Repligen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Repligen is expected to pay a dividend of 0 USD.
What is the dividend yield of Repligen?
The current dividend yield of Repligen is .
When does Repligen pay dividends?
Repligen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Repligen?
Repligen paid dividends every year for the past 0 years.
What is the dividend of Repligen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Repligen located?
Repligen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Repligen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Repligen from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did Repligen pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of Repligen in the year 2023?
In the year 2023, Repligen distributed 0 USD as dividends.
In which currency does Repligen pay out the dividend?
The dividends of Repligen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Repligen stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank
Andere Kennzahlen von Repligen
Our stock analysis for Repligen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Repligen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
